Project Grant HT9425261E159
Award Date 9/30/26
Completion Date 9/29/30
Dollars Obligated $2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1.54M project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award funds research activities focused on assessing prognoses and validating surrogate endpoints for clinical outcomes in metastatic hormone-sensitive prostate cancer. This research initiative aligns with the Defense...
- Federal Project Grant Award Summary Duke University's Office of Research Administration has been awarded $489,987 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year project beginning September 1, 2026, and concluding August 31, 2029. The project, titled "Metastasis-Initiating Cells and Lung Repair as Drivers of Metastasis in Undifferentiated Pleomorphic Sarcoma (UPS): Biologic and Therapeutic Implications," will...
- The Department of Defense's Defense Health Agency awarded Duke University a $1,344,946 Project Grant on September 1, 2023 through the Military Medical Research and Development program (CFDA 12.420). This grant supports a 3-year research project titled "Understanding Heterogeneity and Improving the Precision of Prostate Cancer Clinical Outcomes in the Modern Era." The research aims to advance understanding and treatment of prostate cancer, with a focus on improving clinical outcomes for...
- Federal Project Grant Award Summary Award: The Defense Health Agency (DHA), through its Military Medical Research and Development program (CFDA 12.420), awarded Duke University's Office of Research Administration a Project Grant of $564,705 on September 15, 2025, for research extending through September 14, 2028. The award supports the identification of oncofusion-interacting proteins as essential drug targets for common and rare oncofusions in rhabdomyosarcoma. This research initiative aligns...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $700,032 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award supports research titled "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC" (Renal Cell Carcinoma), with work performed at Duke's Durham,...
- Federal Project Grant Award Summary Duke University's Office of Research Administration was awarded $490,000 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year project beginning September 1, 2026, and concluding August 31, 2029. The project, titled "Genotype-Phenotype Modeling of Rare Sinonasal Tumors to Enable Precision Oncology," will deliver research services focused on developing computational and...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $2.41M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds research into cognitive rehabilitation interventions for the treatment of anger in veterans with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Research activities will be conducted...
- Federal Project Grant Award Summary Duke University's Office of Research Administration was awarded $845,250 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning July 1, 2025, through June 30, 2028. The project focuses on engineering T-cell receptor (TCR)-modified T cells designed to target human endogenous retroviruses for non-small cell lung cancer immunotherapy. This research initiative represents an advanced biomedical research...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Duke University's Office of Research Administration a $696,154 Project Grant on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year investigation through August 31, 2029. This research initiative, titled "Off-Target Effects of Breast Cancer Adjuvant Radiation Therapy on Thymus Function in Young Women," is designed to examine the unintended...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $139,881 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2026. The research project, titled "Investigating Tumor-Osteoclast Interactions in the Chondrosarcoma Microenvironment and Its Effect on Metastatic Disease Progression," will be conducted in Durham, North Carolina, with a completion date...